Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up

Four patients with chronic refractory immune thrombocytopenic purpura (ITP) received human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). The hUC-MSC dose was 5×10(7) to 1×10(8). Complete remission (CR) was achieved in three patients in 12 months and one patient in 24 months. Three patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaohua, Yin, Xiaoguang, Sun, Wei, Bai, Jin, Shen, Yawen, Ao, Qiang, Gu, Yongquan, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443306/
https://www.ncbi.nlm.nih.gov/pubmed/28565834
http://dx.doi.org/10.3892/etm.2017.4229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443306/
https://www.ncbi.nlm.nih.gov/pubmed/28565834
http://dx.doi.org/10.3892/etm.2017.4229

Ejemplares similares